Zachary Schwager to Humans
This is a "connection" page, showing publications Zachary Schwager has written about Humans.
Connection Strength
0.291
-
Clinical epidemiology and treatment of lichen planus: A retrospective review of 2 tertiary care centers. J Am Acad Dermatol. 2019 12; 81(6):1397-1399.
Score: 0.063
-
Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid. J Am Acad Dermatol. 2019 06; 80(6):e189-e190.
Score: 0.062
-
Superficial acral fibromyxoma and other slow-growing tumors in acral areas. Cutis. 2015 Feb; 95(2):E15-9.
Score: 0.047
-
Part I: Epidemiology, pathophysiology, and clinical considerations of primary and secondary Raynaud's phenomenon. J Am Acad Dermatol. 2024 02; 90(2):223-234.
Score: 0.020
-
Part II: The treatment of primary and secondary Raynaud's phenomenon. J Am Acad Dermatol. 2024 02; 90(2):237-248.
Score: 0.020
-
Identification and Management of Night Eating Syndrome in the Adolescent and Young Adult Population. Prim Care Companion CNS Disord. 2022 Feb 17; 24(1).
Score: 0.019
-
Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient disease. J Am Acad Dermatol. 2021 Jun; 84(6):1547-1553.
Score: 0.017
-
Assessment of Antimalarial Therapy in Patients Who Are Hypersensitive to Hydroxychloroquine. JAMA Dermatol. 2019 Apr 01; 155(4):491-493.
Score: 0.016
-
The clinical effects of l-arginine and asymmetric dimethylarginine: implications for treatment in secondary Raynaud's phenomenon. J Eur Acad Dermatol Venereol. 2019 Mar; 33(3):497-503.
Score: 0.015
-
A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud's phenomenon. J Am Acad Dermatol. 2018 Jun; 78(6):1110-1118.e3.
Score: 0.015